Evidence map›Paper›PMID 38257392›Full record

ArticleMolecules (Basel, Switzerland)2024

Phenolic Content Analysis of Two Species Belonging to the

Ashwell R Ndhlala, Mesut Işık, Arzu Kavaz Yüksel, Emrah Dikici

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
6.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Metabolite Profiling of Lavender (Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Artificial Intelligence-Assisted Optimization ofFoods (Basel, Switzerland) · 2026
    Article
  4. Establishment of Shoot Cultures ofInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Anticancer Effects and Phytochemical Profile ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Antidiabetic potential ofFrontiers in pharmacology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Ashwell R NdhlalaGreen Biotechnologies Research Centre, School of Agricultural and Environmental Sciences, University of Limpopo, Private Bag X1106, Sovenga 0727, South Africa.ORCID 0000-0002-7290-3175
Mesut IşıkDepartment of Bioengineering, Faculty of Engineering, Bilecik Şeyh Edebali University, Bilecik 11230, Turkey.ORCID 0000-0002-4677-8104
Arzu Kavaz YükselDepartment of Food Technology, Technical Sciences Vocational School, Atatürk University, Erzurum 25030, Turkey.ORCID 0000-0001-8292-9259
Emrah DikiciScience and Technology Application and Research Center, Aksaray University, Aksaray 68100, Turkey.ORCID 0000-0002-3086-8156
Aksaray University · TRAtatürk University · TRBilecik Şeyh Edebali Üniversitesi · TRUniversity of Limpopo · ZA

Funding

the Department of Science and Innovation. Pretoria (South African Government) DSI/CON C2235/2021
6 · The paper itself

Abstract

The

Indexed as

LamiaceaeThymus PlantAcetylcholinesteraseAnti-Bacterial AgentsAntioxidantsCholinergic AntagonistsChromatography, LiquidDietary SupplementsEthanolTandem Mass SpectrometryAcetylcholinesteraseAnti-Bacterial AgentsAntioxidantsCholinergic AntagonistsEthanolacetylcholinesteraseantibacterialantioxidantLamiaceae speciesphenolic profiles

Identifiers

PMID38257392
PMCPMC10821218
OpenAlexW4390973303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.